Home
About
FAQ
History (11)
Pseudobulbar affect: prevalence and quality of life impact in movement disorders.
Weight change following deep brain stimulation for movement disorders.
Deep brain stimulation for the treatment of Alzheimer disease and dementias.
Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia.
Coding for the use of botulinum toxin for movement disorders.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Coding for the use of botulinum toxin for movement disorders.
Brashear A, Bushong L. Coding for the use of botulinum toxin for movement disorders. Continuum (Minneap Minn). 2013 Oct; 19(5 Movement Disorders):1406-15.
View in:
PubMed
subject areas
Anti-Dyskinesia Agents
Botulinum Toxins
Documentation
Drug Costs
Humans
Injections
Medication Systems
Movement Disorders
Off-Label Use
Patient Acceptance of Health Care